世界のマントル細胞リンパ腫治療市場:販売動向2018

【英語タイトル】Global Mantle Cell Lymphoma Treatment Sales Market Report 2018

QYResearchが出版した調査資料(QYR8021091)・商品コード:QYR8021091
・発行会社(調査会社):QYResearch
・発行日:2018年1月16日
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥460,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥920,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、マントル細胞リンパ腫治療の世界市場について調査・分析し、マントル細胞リンパ腫治療のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、マントル細胞リンパ腫治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・マントル細胞リンパ腫治療市場概要
・マントル細胞リンパ腫治療のメーカー別販売量・メーカー別シェア
・マントル細胞リンパ腫治療の世界市場:種類別販売量・市場シェア
・マントル細胞リンパ腫治療の世界市場:用途別販売量・市場シェア
・マントル細胞リンパ腫治療の世界市場:地域別販売量・市場シェア
・マントル細胞リンパ腫治療のアメリカ市場規模
・マントル細胞リンパ腫治療の中国市場規模
・マントル細胞リンパ腫治療のヨーロッパ市場規模
・マントル細胞リンパ腫治療の日本市場規模
・マントル細胞リンパ腫治療の東南アジア市場規模
・マントル細胞リンパ腫治療のインド市場規模
・マントル細胞リンパ腫治療のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・マントル細胞リンパ腫治療のコスト分析・価格動向
・マントル細胞リンパ腫治療の産業チェーン(サプライチェーン分析)
・マントル細胞リンパ腫治療のマーケティング戦略・販売チャネル、流通業者
・マントル細胞リンパ腫治療市場への影響要因分析
・マントル細胞リンパ腫治療の世界市場予測
・マントル細胞リンパ腫治療のアメリカ市場予測
・マントル細胞リンパ腫治療の中国市場予測
・マントル細胞リンパ腫治療のヨーロッパ市場予測
・マントル細胞リンパ腫治療の日本市場予測
・マントル細胞リンパ腫治療の東南アジア市場予測
・マントル細胞リンパ腫治療のインド市場予測
・マントル細胞リンパ腫治療の種類別世界市場予測
・マントル細胞リンパ腫治療の用途別世界市場予測
...
【レポートの概要】

In this report, the global Mantle Cell Lymphoma Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Mantle Cell Lymphoma Treatment for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Mantle Cell Lymphoma Treatment market competition by top manufacturers/players, with Mantle Cell Lymphoma Treatment sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Mantle Cell Lymphoma Treatment Sales Market Report 2018
1 Mantle Cell Lymphoma Treatment Market Overview
1.1 Product Overview and Scope of Mantle Cell Lymphoma Treatment
1.2 Classification of Mantle Cell Lymphoma Treatment by Product Category
1.2.1 Global Mantle Cell Lymphoma Treatment Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Mantle Cell Lymphoma Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Acalabrutinib
1.2.4 JCAR-017
1.2.5 JNJ-64052781
1.2.6 Acalisib
1.2.7 IGN-002
1.2.8 IMGN-529
1.2.9 AFM-11
1.2.10 Others
1.3 Global Mantle Cell Lymphoma Treatment Market by Application/End Users
1.3.1 Global Mantle Cell Lymphoma Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mantle Cell Lymphoma Treatment Market by Region
1.4.1 Global Mantle Cell Lymphoma Treatment Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.4.3 China Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.4.4 Europe Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.4.5 Japan Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.4.6 Southeast Asia Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.4.7 India Mantle Cell Lymphoma Treatment Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Mantle Cell Lymphoma Treatment (2013-2025)
1.5.1 Global Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2025)
1.5.2 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2025)

2 Global Mantle Cell Lymphoma Treatment Competition by Players/Suppliers, Type and Application
2.1 Global Mantle Cell Lymphoma Treatment Market Competition by Players/Suppliers
2.1.1 Global Mantle Cell Lymphoma Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Mantle Cell Lymphoma Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Mantle Cell Lymphoma Treatment (Volume and Value) by Type
2.2.1 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Type (2013-2018)
2.2.2 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Type (2013-2018)
2.3 Global Mantle Cell Lymphoma Treatment (Volume and Value) by Region
2.3.1 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Region (2013-2018)
2.3.2 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Region (2013-2018)
2.4 Global Mantle Cell Lymphoma Treatment (Volume) by Application

3 United States Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
3.1 United States Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
3.1.1 United States Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
3.1.2 United States Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
3.1.3 United States Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
3.2 United States Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
3.3 United States Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
3.4 United States Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

4 China Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
4.1 China Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
4.1.1 China Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
4.1.2 China Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
4.1.3 China Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
4.2 China Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
4.3 China Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
4.4 China Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

5 Europe Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
5.1 Europe Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
5.1.1 Europe Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
5.1.2 Europe Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
5.1.3 Europe Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
5.2 Europe Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

6 Japan Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
6.1 Japan Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
6.1.1 Japan Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
6.1.2 Japan Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
6.1.3 Japan Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
6.2 Japan Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
7.1 Southeast Asia Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
7.1.1 Southeast Asia Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
7.2 Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

8 India Mantle Cell Lymphoma Treatment (Volume, Value and Sales Price)
8.1 India Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
8.1.1 India Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
8.1.2 India Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
8.1.3 India Mantle Cell Lymphoma Treatment Sales Price Trend (2013-2018)
8.2 India Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Players (2013-2018)
8.3 India Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Type (2013-2018)
8.4 India Mantle Cell Lymphoma Treatment Sales Volume and Market Share by Application (2013-2018)

9 Global Mantle Cell Lymphoma Treatment Players/Suppliers Profiles and Sales Data
9.1 Astex Pharmaceuticals, Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Bayer AG
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bayer AG Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bristol-Myers Squibb Company
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Celgene Corporation
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Cellular Biomedicine Group, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Eisai
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Eisai Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 EpiZyme, Inc.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Fate Therapeutics, Inc.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Genentech, Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Gilead Sciences, Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 GlaxoSmithKline Plc
9.12 Hutchison MediPharma Limited
9.13 ImmunoGen, Inc.
9.14 Immunomedics, Inc.

10 Mantle Cell Lymphoma Treatment Maufacturing Cost Analysis
10.1 Mantle Cell Lymphoma Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment
10.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Mantle Cell Lymphoma Treatment Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Mantle Cell Lymphoma Treatment Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Mantle Cell Lymphoma Treatment Market Forecast (2018-2025)
14.1 Global Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Mantle Cell Lymphoma Treatment Price and Trend Forecast (2018-2025)
14.2 Global Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 China Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 Europe Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Mantle Cell Lymphoma Treatment Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Mantle Cell Lymphoma Treatment Sales Forecast by Type (2018-2025)
14.3.2 Global Mantle Cell Lymphoma Treatment Revenue Forecast by Type (2018-2025)
14.3.3 Global Mantle Cell Lymphoma Treatment Price Forecast by Type (2018-2025)
14.4 Global Mantle Cell Lymphoma Treatment Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Mantle Cell Lymphoma Treatment
Figure Global Mantle Cell Lymphoma Treatment Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Acalabrutinib Product Picture
Figure JCAR-017 Product Picture
Figure JNJ-64052781 Product Picture
Figure Acalisib Product Picture
Figure IGN-002 Product Picture
Figure IMGN-529 Product Picture
Figure AFM-11 Product Picture
Figure Others Product Picture
Figure Global Mantle Cell Lymphoma Treatment Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Mantle Cell Lymphoma Treatment by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Mantle Cell Lymphoma Treatment Market Size (Million USD) by Regions (2013-2025)
Figure United States Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Mantle Cell Lymphoma Treatment Sales Share by Players/Suppliers
Figure 2017 Mantle Cell Lymphoma Treatment Sales Share by Players/Suppliers
Figure Global Mantle Cell Lymphoma Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Mantle Cell Lymphoma Treatment Revenue Share by Players
Table 2017 Global Mantle Cell Lymphoma Treatment Revenue Share by Players
Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Type (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Sales Growth Rate by Type (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Mantle Cell Lymphoma Treatment by Type (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Revenue Growth Rate by Type (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Region (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Sales Growth Rate by Region in 2017
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Mantle Cell Lymphoma Treatment by Region (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Revenue Growth Rate by Region in 2017
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Mantle Cell Lymphoma Treatment by Region (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share by Region in 2017
Table Global Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Mantle Cell Lymphoma Treatment Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Application (2013-2018)
Figure Global Mantle Cell Lymphoma Treatment Sales Market Share by Application (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table United States Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table United States Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure United States Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Figure China Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table China Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table China Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table China Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure China Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Figure Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table Europe Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table Europe Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Figure Japan Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table Japan Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table Japan Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure Japan Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Figure India Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table India Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players (2013-2018)
Figure India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Players in 2017
Table India Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (2013-2018)
Figure India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type in 2017
Table India Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application (2013-2018)
Figure India Mantle Cell Lymphoma Treatment Sales Volume Market Share by Application in 2017
Table Astex Pharmaceuticals, Inc. Basic Information List
Table Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Cellular Biomedicine Group, Inc. Basic Information List
Table Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Eisai Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018
Figure Eisai Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table EpiZyme, Inc. Basic Information List
Table EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Fate Therapeutics, Inc. Basic Information List
Table Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Genentech, Inc. Basic Information List
Table Genentech, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table Gilead Sciences, Inc. Basic Information List
Table Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table Hutchison MediPharma Limited Basic Information List
Table ImmunoGen, Inc. Basic Information List
Table Immunomedics, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mantle Cell Lymphoma Treatment
Figure Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment
Figure Mantle Cell Lymphoma Treatment Industrial Chain Analysis
Table Raw Materials Sources of Mantle Cell Lymphoma Treatment Major Players in 2017
Table Major Buyers of Mantle Cell Lymphoma Treatment
Table Distributors/Traders List
Figure Global Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Volume Market Share Forecast by Regions in 2025
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Global Mantle Cell Lymphoma Treatment Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

マントル細胞リンパ腫治療

★調査レポート[世界のマントル細胞リンパ腫治療市場:販売動向2018] (コード:QYR8021091)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のマントル細胞リンパ腫治療市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆